AbCellera Biologics
ABCL
ABCL
140 hedge funds and large institutions have $525M invested in AbCellera Biologics in 2025 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 42 increasing their positions, 35 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
10% more funds holding
Funds holding: 127 → 140 (+13)
1.25% less ownership
Funds ownership: 36.06% → 34.81% (-1.3%)
Holders
140
Holding in Top 10
–
Calls
$9.54M
Puts
$5.18M
Top Buyers
| 1 | +$11M | |
| 2 | +$9.03M | |
| 3 | +$6.17M | |
| 4 |
Two Sigma Investments
New York
|
+$5.35M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$4.15M |
Top Sellers
| 1 | -$29.1M | |
| 2 | -$11.5M | |
| 3 | -$9.46M | |
| 4 |
Millennium Management
New York
|
-$4.87M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$4.82M |
